Spermicidal efficacy for STD prevention can be identified in six-month trials, cmte. told.
This article was originally published in The Tan Sheet
Executive Summary
SIX-MONTH SPERMICIDE TRIALS ARE ADEQUATE TO DEMONSTRATE EFFICACY OF STD PREVENTION, given the plethora of compliance problems associated with long-term efficacy studies, Lisa Kaiser, Alan Guttmacher Institute, recommended Nov. 20 at the joint FDA advisory committee meeting on spermicides in Gaithersburg, Md. Questioning the emphasis placed on long-term efficacy studies, Kaiser pointed to the difficulty and cost associated with such trials, which stems mainly from participants' reluctance to use spermicides for long periods of time.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning